Compound ID | 2939
Class: Drug efflux pump inhibitor
Spectrum of activity: | Gram-negative |
Details of activity: | Active against Escherichia coli; efflux pump AcrB inhibitor |
Description: | Synthetic compound; reduces MIC of several antibiotics (ex: oxacillin, pyridomycin, linezolid, novobiocin, fusidic acid, chloramphenicol); no intrinsic antibacterial activity |
Institute where first reported: | Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019—UMR 9017—CIIL—Center for Infection and Immunity of Lille, F-59000 Lille, France |
Year first mentioned: | 2022 |
Development status: | Experimental |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/153987774 |
Citation: | https://www.nature.com/articles/s41467-021-27726-2 |